DBVT (DBV Technologies S.A.) Stock Financials & Earnings | Market Cap Arena

DBVT (DBV Technologies S.A.) Stock Financials & Earnings | Market Cap Arena

DBVTDBV Technologies S.A.

Mkt Cap$560M

Healthcare·Biotechnology·🇫🇷 France·NASDAQ

Revenue (TTM)$511,000

Net Income (TTM)-$126M

EPS (TTM)-$5.80

Free Cash Flow (TTM)-$98M

Gross Margin-2518.1%

Op. Margin-25685.2%

Net Margin-24566.2%

FCF Margin-19234.2%

P/S Ratio (TTM)1096.1x

P/E Ratio (TTM)—

YoY Rev Growth-95.5%

Employees—

Earnings Reports

Next: Q4 2025 · Apr 10

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	-$1M	-$1M	-$38M
Q1 23	$2M	$2M	-$21M
Q2 23	$2M	$2M	-$25M
Q3 23	$0	-$456K	-$21M
Q4 23	$9M	$9M	-$12M
Q1 24	$1M	$1M	-$29M
Q2 24	$0	-$4M	-$35M
Q3 24	$1M	$1M	-$30M
Q4 24	$511K	$511K	-$24M
Q1 25	$0	-$4M	-$27M
Q2 25	$0	-$5M	-$43M
Q3 25	$0	-$4M	-$37M

Valuation

Quarter	P/S	P/E
Q4 22	—	—
Q1 23	629.4x	—
Q2 23	176.3x	—
Q3 23	176.3x	—
Q4 23	41.9x	—
Q1 24	44.6x	—
Q2 24	54.5x	—
Q3 24	49.3x	—
Q4 24	187.3x	—
Q1 25	353.8x	—
Q2 25	353.8x	—
Q3 25	1096.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$24M	-$24M
Q1 23	-$21M	-$21M
Q2 23	-$26M	-$26M
Q3 23	-$20M	-$20M
Q4 23	-$14M	-$14M
Q1 24	-$35M	-$36M
Q2 24	-$35M	-$36M
Q3 24	-$22M	-$23M
Q4 24	-$12M	-$12M
Q1 25	-$20M	-$20M
Q2 25	-$34M	-$34M
Q3 25	-$32M	-$33M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$12K
Q1 23	$111K
Q2 23	$164K
Q3 23	$50K
Q4 23	$352K
Q1 24	$1M
Q2 24	$732K
Q3 24	$396K
Q4 24	$125K
Q1 25	$10K
Q2 25	$32K
Q3 25	$117K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	-144.5%	+123.7%
Q1 23	—	+21.2%
Q2 23	—	+8.7%
Q3 23	—	+2.7%
Q4 23	+780.6%	-43.4%
Q1 24	-35.9%	+28.3%
Q2 24	-100.0%	+27.8%
Q3 24	—	+52.9%
Q4 24	-94.2%	+17.2%
Q1 25	-100.0%	-8.6%
Q2 25	—	+23.3%
Q3 25	-100.0%	+17.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$2M	—
Q1 23	$2M	74.4%
Q2 23	$2M	79.3%
Q3 23	$1M	—
Q4 23	$1M	13.7%
Q1 24	$2M	139.2%
Q2 24	$2M	—
Q3 24	$2M	148.3%
Q4 24	-$453K	-88.6%
Q1 25	$0	—
Q2 25	$1M	—
Q3 25	$516K	—

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q4 22	$30M	$7M	$51K	—
Q1 23	$16M	$7M	$434K	—
Q2 23	$18M	$9M	$516K	—
Q3 23	$16M	—	—	$4M
Q4 23	$13M	$7M	$825K	—
Q1 24	$21M	$6M	—	—
Q2 24	$24M	—	—	$7M
Q3 24	$24M	$6M	—	—
Q4 24	$19M	$5M	$396K	—
Q1 25	$19M	—	—	$4M
Q2 25	$32M	—	—	$7M
Q3 25	$27M	$6M	—	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$209M	$0	$209M
Q1 23	$192M	$0	$192M
Q2 23	$174M	$0	$174M
Q3 23	$149M	$0	$149M
Q4 23	$141M	$0	$141M
Q1 24	$102M	$0	$102M
Q2 24	$66M	$0	$66M
Q3 24	$46M	$0	$46M
Q4 24	$32M	$0	$32M
Q1 25	$13M	$0	$13M
Q2 25	$103M	$0	$103M
Q3 25	$70M	$0	$70M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	19M	+0.0%
Q1 23	19M	+0.1%
Q2 23	19M	+0.4%
Q3 23	20M	+4.1%
Q4 23	19M	-2.2%
Q1 24	20M	+1.5%
Q2 24	19M	-1.4%
Q3 24	19M	+0.0%
Q4 24	19M	+0.0%
Q1 25	21M	+6.7%
Q2 25	19M	-6.3%
Q3 25	19M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	—	—
FY 14	$5K	56
FY 15	$2K	91
FY 16	$48K	164
FY 17	$47K	244
FY 18	$41K	315
FY 19	$47K	311
FY 20	$80K	141
FY 21	$62K	92
FY 22	$56K	85
FY 23	$151K	104
FY 24	$0	104